Jane Wasman

2009

In 2009, Jane Wasman earned a total compensation of $1.4M as Chief, Strategic Development, General Counsel and Corporate Secretary at Acorda Therapeutics, a 10% increase compared to previous year.

Compensation breakdown

Bonus$211,139
Option Awards$493,988
Salary$341,833
Stock Awards$308,850
Other$7,350
Total$1,363,160

Wasman received $494K in option awards, accounting for 36% of the total pay in 2009.

Wasman also received $211.1K in bonus, $341.8K in salary, $308.9K in stock awards and $7.4K in other compensation.

Rankings

In 2009, Jane Wasman's compensation ranked 3,483rd out of 9,885 executives tracked by ExecPay. In other words, Wasman earned more than 64.8% of executives.

ClassificationRankingPercentile
All
3,483
out of 9,885
65th
Division
Manufacturing
1,218
out of 3,690
67th
Major group
Chemicals And Allied Products
237
out of 866
73rd
Industry group
Drugs
137
out of 638
79th
Industry
Biological Products, Except Diagnostic Substances
20
out of 133
85th
Source: SEC filing on April 26, 2012.

Wasman's colleagues

We found four more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2009.

2009

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2009

Andrew Blight

Acorda Therapeutics

Chief Scientific Officer

2009

David Lawrence

Acorda Therapeutics

Chief Financial Officer

2009

Thomas Wessel

Acorda Therapeutics

Chief Medical Officer

News

You may also like